TTFields use in special GBM populations and potential combination with immunotherapy
14 Feb 2023
byDr. Alexander Grote, Department of Neurosurgery, University Hospital of Marburg, Germany; Prof. Michael Lim, Department of Neurosurgery, Stanford University, US
Glioblastoma multiforme (GBM) is the most common and aggressive brain tumour with a very poor prognosis. Tumour-treating fields (TTFields) are a relatively new, noninvasive treatment for GBM, which delivers low-intensity alternating electric fields that disrupt cancer cell division. At a recent scientific meeting organized by the Hong Kong Neurosurgical Society, Dr Alexander Grote of the Department of Neurosurgery, University Hospital of Marburg, Germany, and Professor Michael Lim of the Department of Neurosurgery, Stanford University, US, discussed the evolving role of TTFields in managing patients with GBM.
